Aug 6, 2026 07:31AM
Aug 6, 2026 07:30AM
Aug 4, 2026 08:01AM
Aug 4, 2026 08:00AM
Jun 29, 2026 08:01AM
Jun 29, 2026 08:00AM
May 27, 2026 08:00AM Nuvation Bio to present quality-of-life data for IBTROZI at ASCO 2026
May 27, 2026 08:00AM
May 13, 2026 04:05PM
May 13, 2026 04:05PM
May 6, 2026 08:01AM
May 6, 2026 08:00AM
May 4, 2026 04:10PM
Apr 27, 2026 08:00AM Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
Apr 21, 2026 06:00PM
Apr 1, 2026 08:01AM
Apr 1, 2026 08:00AM
Mar 27, 2026 08:50AM
Mar 27, 2026 06:46AM
Mar 26, 2026 04:05PM
Mar 26, 2026 04:05PM Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
Mar 17, 2026 04:35PM
Mar 2, 2026 04:05PM
Feb 9, 2026 08:00AM
Feb 9, 2026 08:00AM
Feb 4, 2026 06:50AM
Jan 12, 2026 08:04AM
Jan 12, 2026 08:00AM Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
Jan 12, 2026 07:33AM
Jan 12, 2026 07:30AM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM
Nov 24, 2025 07:33AM
Nov 19, 2025 01:02AM
Nov 3, 2025 04:05PM Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Oct 23, 2025 07:31AM
Oct 23, 2025 07:30AM
Sep 30, 2025 07:30AM
Sep 30, 2025 07:30AM
Sep 30, 2025 02:04AM
Sep 19, 2025 07:30AM
Sep 19, 2025 07:30AM Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
Sep 11, 2025 08:18AM
Sep 7, 2025 06:00AM
Aug 7, 2025 07:30AM
Aug 5, 2025 08:00AM
Jun 24, 2025 07:00AM
Jun 13, 2025 06:44AM
Jun 13, 2025 05:31AM Citizens JMP Reiterates Market Outperform Rating on Nuvation Bio Inc (NUVB)
Jun 12, 2025 04:13AM

327,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All